News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bavarian Nordic (BAVA.CO) Announces Presentation of PROSTVAC(R) Data at the 2011 American Society of Clinical Oncology Annual Meeting


6/1/2011 10:41:17 AM

KVISTGAARD, Denmark, June 1, 2011 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (Copenhagen:BAVA) today announced that investigators from the National Cancer Institute are presenting at the 2011 ASCO Annual Meeting in Chicago data from a study with PROSTVAC® entitled "Intraprostatic PSA-TRICOM vaccine administration in patients with locally recurrent prostate cancer".

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES